US serial killer case opens door to using cutting-edge DNA data in courts
By Katherine Bourzac,
Nature
| 09. 25. 2025
New York trial could set a legal precedent by admitting findings from whole-genome sequencing as evidence.
A judge in New York rejected a request on 23 September to disqualify the use of cutting-edge DNA sequencing as evidence in a case against an alleged serial killer. The ruling paves the way for a type of DNA analysis known as whole-genome sequencing — used to decipher ancient DNA in fossilized remains, for example — to be admitted as evidence in US criminal trials.
“This is a big step forward for the use of DNA evidence, because it will allow comparisons and matches with evidence that was previously considered too minuscule, too old or too badly degraded to be considered useful,” says Nathan Lents, a biologist at the John Jay College of Criminal Justice in New York City. “You can bet that cold-case units all over the country are going back through their evidence lockers to see if there are samples that can now be tested with a reasonable chance of success.”
A technology matures
The Gilgo Beach killings were a series of murders that occurred in Suffolk County, New York, between 1993 and 2011. Many of the victims...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
